264.40 USD
-3.43
1.28%
At close Apr 25, 4:00 PM EDT
After hours
264.40
+0.00
0.00%
1 day
-1.28%
5 days
0.72%
1 month
-3.42%
3 months
-11.20%
6 months
1.41%
Year to date
4.65%
1 year
-15.10%
5 years
-29.21%
10 years
46.79%
 

About: Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Employees: 65,680

0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

3.79% more ownership

Funds ownership: 92.45% [Q3] → 96.24% (+3.79%) [Q4]

8% more call options, than puts

Call options by funds: $1.86B | Put options by funds: $1.73B

7% less funds holding

Funds holding: 923 [Q3] → 860 (-63) [Q4]

14% less funds holding in top 10

Funds holding in top 10: 14 [Q3] → 12 (-2) [Q4]

15% less capital invested

Capital invested by funds: $34.9B [Q3] → $29.8B (-$5.15B) [Q4]

23% less first-time investments, than exits

New positions opened: 144 | Existing positions closed: 187

26% less repeat investments, than reductions

Existing positions increased: 270 | Existing positions reduced: 364

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$256
3%
downside
Avg. target
$300
14%
upside
High target
$326
23%
upside

9 analyst ratings

positive
33%
neutral
67%
negative
0%
Baird
Michael Ha
45% 1-year accuracy
10 / 22 met price target
13%upside
$300
Neutral
Maintained
15 Apr 2025
Barclays
Andrew Mok
38% 1-year accuracy
22 / 58 met price target
22%upside
$322
Equal-Weight
Maintained
11 Apr 2025
Truist Securities
David Macdonald
54% 1-year accuracy
54 / 100 met price target
23%upside
$325
Hold
Maintained
11 Apr 2025
Guggenheim
Jason Cassorla
14% 1-year accuracy
2 / 14 met price target
23%upside
$326
Buy
Initiated
9 Apr 2025
Mizuho
Ann Hynes
43% 1-year accuracy
9 / 21 met price target
20%upside
$316
Outperform
Maintained
9 Apr 2025

Financial journalist opinion

Based on 22 articles about HUM published over the past 30 days

Positive
Zacks Investment Research
2 days ago
Humana (HUM) Reports Next Week: Wall Street Expects Earnings Growth
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Humana (HUM) Reports Next Week: Wall Street Expects Earnings Growth
Neutral
Business Wire
1 week ago
Humana Board Declares Payment of Quarterly Dividend to Stockholders
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on July 25, 2025 to stockholders of record as of the close of business on June 27, 2025. About Humana Humana Inc. is committed to putting health first – for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of pe.
Humana Board Declares Payment of Quarterly Dividend to Stockholders
Neutral
Business Wire
1 week ago
New Report from the Humana Foundation Examines Best-Practices in Community-Engaged Research
LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. for the past 44 years, today announced the publication of its new report, Strengthening Science and Community Impact Through Equitable Research Practices. The report examines innovative research methods adopted by the Foundation's partners to promote health equity in public health research through community-engaged research practices. “Our report offers pivotal insights and recommendations to help fund.
New Report from the Humana Foundation Examines Best-Practices in Community-Engaged Research
Neutral
MarketBeat
1 week ago
2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs
The medical sector stocks, notably the health insurance carriers, took a major drubbing in 2024 as Medicare Advantage (MA) plans continued to drive higher utilization costs, eating away at profits. These rising costs are illustrated by the medical benefits ratio (MBR), benefits expense ratio (BER), medical care ratio (MCR) or medical loss ratio (MLR), which is the percentage of premiums used to pay for medical services.
2 Healthcare Recession-Resistant Stocks Unaffected by Tariffs
Positive
Market Watch
2 weeks ago
Here are this week's 20 best performers as the S&P 500 rallied
Believe it or not, we just completed a good week for the U.S. stock market. The S&P 500 rose 5.7% through Friday's close from a week earlier, with three-quarters of component stocks showing gains.
Here are this week's 20 best performers as the S&P 500 rallied
Neutral
Kiplinger
2 weeks ago
Which Stocks Stayed Green as the Market Plummeted?
Only a handful of S&P 500 stocks managed to generate gains during the market's historic four-day plunge.
Which Stocks Stayed Green as the Market Plummeted?
Positive
Zacks Investment Research
2 weeks ago
UnitedHealth vs. Humana: Which Healthcare Stock Should You Buy Now?
The CMS announced a hike in MA payments for fiscal year 2026, which will likely deliver a notable boost to UNH & HUM's bottom lines.
UnitedHealth vs. Humana: Which Healthcare Stock Should You Buy Now?
Positive
Zacks Investment Research
2 weeks ago
Humana (HUM) Surges 10.7%: Is This an Indication of Further Gains?
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Humana (HUM) Surges 10.7%: Is This an Indication of Further Gains?
Neutral
Business Wire
2 weeks ago
Humana's Initiatives Deliver Improved Health Outcomes in Communities
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana's Initiatives Deliver Improved Health Outcomes in Communities.
Humana's Initiatives Deliver Improved Health Outcomes in Communities
Negative
CNBC Television
2 weeks ago
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthcare companies aren't getting more investor respect despite their percentage of national output, and more.
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Charts implemented using Lightweight Charts™